Youichi Suzuki

This study identifies anisomycin as a potential antiviral agent against chikungunya virus, showing it inhibits viral replication and reduces disease symptoms in vitro and in vivo through a mechanism distinct from its known functions.

This study identifies ORF29 as a critical component of the KSHV terminase complex, essential for capsid formation and TR cleavage, and shows it interacts with itself and ORF7.